Truist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $18
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and raises the price target from $15 to $18.
Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and raises the price target from $15 to $18.